Development of antibody-siRNA conjugate targeted to cardiac and skeletal muscles

被引：139

作者：

Sugo, Tsukasa ^{[1
]}

Terada, Michiko ^{[1
]}

Oikawa, Tatsuo ^{[2
]}

Miyata, Kenichi ^{[1
]}

Nishimura, Satoshi ^{[2
]}

Kenjo, Eriya ^{[1
]}

Ogasawara-Shimizu, Mari ^{[1
]}

Makita, Yukimasa ^{[1
]}

Imaichi, Sachiko ^{[1
]}

Murata, Shumpei ^{[1
]}

Otake, Kentaro ^{[1
]}

Kikuchi, Kuniko ^{[1
]}

Teratani, Mika ^{[1
]}

Masuda, Yasushi ^{[1
]}

Kamei, Takayuki ^{[1
]}

Takagahara, Shuichi ^{[2
]}

Ikeda, Shota ^{[2
]}

Ohtaki, Tetsuya ^{[1
]}

Matsumoto, Hirokazu ^{[1
]}

机构：

[1] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Integrated Technol Res Labs, 26-1 Muraoka Higashi 2-Chome, Fujisawa, Kanagawa 2518555, Japan

[2] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Cardiovasc & Metab Drug Discovery Unit, 26-1 Muraoka Higashi 2-Chome, Fujisawa, Kanagawa 2518555, Japan

来源：

JOURNAL OF CONTROLLED RELEASE | 2016年 / 237卷

关键词：

Skeletal muscle; Heart; CD71; Transferrin; siRNA; Conjugate; Myostatin; Peripheral artery disease (PAD); Drug delivery system; Targeting; Antibody; Intramuscular injection; PERIPHERAL ARTERIAL-DISEASE; SMALL INTERFERING RNAS; BLOOD-BRAIN-BARRIER; TRANSFERRIN RECEPTOR; IN-VIVO; MONOCLONAL-ANTIBODY; CELL-PROLIFERATION; HEART-FAILURE; DNA UPTAKE; MYOSTATIN;

D O I：

10.1016/j.jconrel.2016.06.036

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Despite considerable efforts to develop efficient carriers, the major target organ of short-interfering RNAs (siRNAs) remains limited to the liver. Expanding the application outside the liver is required to increase the value of siRNAs. Here we report on a novel platform targeted to muscular organs by conjugation of siRNAs with anti-CD71 Fab' fragment. This conjugate showed durable gene-silencing in the heart and skeletal muscle for one month after intravenous administration in normal mice. In particular, 1 mu g siRNA conjugate showed significant gene-silencing in the gastrocnemius when injected intramuscularly. In a mouse model of peripheral artery disease, the treatment with myostatin-targeting siRNA conjugate by intramuscular injection resulted in significant silencing of myostatin and hypertrophy of the gastrocnemius, which was translated into the recovery of running performance. These data demonstrate the utility of antibody conjugation for siRNA delivery and the therapeutic potential for muscular diseases. (C) 2016 Elsevier B.V. All rights reserved.

引用

页码：1 / 13

页数：13

共 53 条

[11] French RR, 2000, METH MOLEC MED, V40, P333, DOI 10.1007/978-1-59259-076-6_26
[12] ANTITRANSFERRIN RECEPTOR ANTIBODY AND ANTIBODY-DRUG CONJUGATES CROSS THE BLOOD-BRAIN-BARRIER
FRIDEN, PM
WALUS, LR
MUSSO, GF
TAYLOR, MA
MALFROY, B
STARZYK, RM
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (11) : 4771 - 4775
[13] FUTRAN J, 1989, J IMMUNOL, V143, P787
[14] TRANSFERRIN RECEPTORS IN HUMAN-TISSUES - THEIR DISTRIBUTION AND POSSIBLE CLINICAL RELEVANCE
GATTER, KC
BROWN, G
TROWBRIDGE, IS
WOOLSTON, RE
MASON, DY
[J]. JOURNAL OF CLINICAL PATHOLOGY, 1983, 36 (05) : 539 - 545
[15] Gene therapy for heart failure
Greenberg, Barry
[J]. JOURNAL OF CARDIOLOGY, 2015, 66 (3-4) : 195 - 200
[16] Myostatin/activin pathway antagonism: Molecular basis and therapeutic potential
Han, H. Q.
Zhou, Xiaolan
Mitch, William E.
Goldberg, Alfred L.
[J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2013, 45 (10) : 2333 - 2347
[17] Preclinical PK and PD Studies on 2′-O-Methyl-phosphorothioate RNA Antisense Oligonucleotides in the mdx Mouse Model
Heemskerk, Hans
de Winter, Christa
van Kuik, Petra
Heuvelmans, Niki
Sabatelli, Patrizia
Rimessi, Paola
Braghetta, Paola
van Ommen, Gert-Jan B.
de Kimpe, Sjef
Ferlini, Alessandra
Aartsma-Rus, Annemieke
van Deutekom, Judith C. T.
[J]. MOLECULAR THERAPY, 2010, 18 (06) : 1210 - 1217
[18] Incidence of and risk factors for asymptomatic peripheral arterial occlusive disease: A longitudinal study
Hooi, JD
Kester, ADM
Stoffers, HEJH
Overdijk, MM
van Ree, JW
Knottnerus, JA
[J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (07) : 666 - 672
[19] THE PHYSIOLOGY OF TRANSFERRIN AND TRANSFERRIN RECEPTORS
HUEBERS, HA
FINCH, CA
[J]. PHYSIOLOGICAL REVIEWS, 1987, 67 (02) : 520 - 582
[20] Antibody drug conjugates - Trojan horses in the war on cancer
Iyer, U.
Kadambi, V. J.
[J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2011, 64 (03) : 207 - 212

← 1 2 3 4 5 6 →